| Product NDC: | 0409-2029 |
| Proprietary Name: | Morphine Sulfate |
| Non Proprietary Name: | MORPHINE SULFATE |
| Active Ingredient(s): | 1 mg/mL & nbsp; MORPHINE SULFATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0409-2029 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019916 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19921030 |
| Package NDC: | 0409-2029-02 |
| Package Description: | 10 CARTON in 1 CONTAINER (0409-2029-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 30 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 0409-2029-02 |
| Proprietary Name | Morphine Sulfate |
| Package Description | 10 CARTON in 1 CONTAINER (0409-2029-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 30 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0409-2029 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | MORPHINE SULFATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19921030 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | MORPHINE SULFATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |